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INTRODUCTION
Life without electricity in the 21st century is unthinkable, since 
almost our entire existence has become dependent on electric-
ity and wireless telecommunication.[1] Where electricity is gen-
erated, electromagnetic fields (EMFs) are created.[2] Advanced 
electrical technology has created an electromagnetic environ-
ment in which people live and work, resulting in constant con-
cern about the environment and human health.
EMFs comprise a wide spectrum of frequency, which ranges 
from extremely high at the highest end of the ionising spectrum 
to extremely low at the lowest end of the non-ionising spec-
trum. The field of interest for this study fell within the extremely 
low frequency (ELF) spectrum between 50 and 60 Hz. These are 
the fields to which people are exposed on a daily basis, through 
household appliances, computers and telecommunication.[2-4] 
Low frequency (LF) fields (which extend from the higher end of 
the ELF band up to 300GHz) have been suggested to be harm-
ful to human health.[5,6] Some research efforts have indicated 
that there is no conclusive evidence that exposure to low field-
strength EMFs poses a health risk.[2,3,7,8] It is this uncertainty that 
has elicited the on-going research in this area for the last three 
decades.[2] The evidence and claims of scientists in this regard 
have been found to be somewhat controversial.[2,3,7,8] It seems 
that short-term exposure to ELF-EMF does not have a detrimen-
tal effect on human biological systems,[9] while long-term expo-
sure can cause chronic stress, resulting in tissue damage.[10,11,8]
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ABsTRACT
There is increasing evidence that extremely low frequency (ELF) electromagnetic fields (EMFs) interact with immune cells. Even 
more evident is that immune cells are activated when exposed to these fields for a short period. Signal specificity and dosimetry 
appear to play a role. In this study, four groups of laboratory mice received daily exposure to a specific electromagnetic field with 
an intensity of 5µT for one hour, four hours and twenty-four hours (continuously) respectively for a period of seven days. The control 
group received no exposure and was used as standard for comparison. Following exposure, whole blood was analysed for leukocyte 
count, CD3, CD4, CD8 and CD19 analysis. The results for the twenty-four hour exposure group indicated increased total leukocyte, 
lymphocyte, CD3 and CD4 values and a decreased neutrophil values. These findings provide evidence that the immune system is 
indeed stimulated by exposure to EMFs.
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There has been growing interest in studies that indicate the 
possibility of therapeutic and health benefits from short-term 
exposure to ELF-EMFs.[12-16] Recently, the immune system has 
been targeted for research in this field. It was found that short-
term exposure to fields in the ELF range affects the blood cell 
levels and results in lymphocyte proliferation.[4] This same 
research group indicated an increased phagocytic activity in 
macrophages; hence, indicating an effect on the innate immune 
response. Several authors suggested that short-term exposure to 
ELF-EMF could stimulate the immune response, specifically on 
a cellular level, leading to the production of cytokines.[17,18,4,16] 
The research of Cuppen et al.[17] led to a hypothesis that ELF-
EMF could alert or stimulate the immune system through mild 
stress induction on cells due to cytokine production. Simkó and 
Mattson assumed an effect at cellular level, where cells respond 
to EMF by reacting as they would to an unspecific stressor.[13] 
However, sufficient supporting evidence to validate this postu-
lation is lacking.
Recent research studies indicated that exposure to a specific 
EMF signal (the Immunent BV signal with multiple waveforms 
[20-5000Hz]) led to decreased mortality in fish[17] and also im-
proved the feed conversion in chickens.[19] In addition, this same 
signal proved to enhance the immune system when a study on 
chickens, infected with coccidiosis, indicated reduced intesti-
nal lesions after exposure to this specific signal.[19] The patented 
Immunent signal[20] is created by a device which emits a specific 
ELF-EMF signal with a different waveform and intensity from a 
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standard therapeutic signal.[16] With this specific signal, several 
research studies have shown that short-term exposure to the 
signal enhances the immune system.[4,13,17,19]
The hypothesis by Cuppen et al.[20] suggests cytokine involve-
ment needs to be investigated further, specifically in mammals. 
Once validated, this hypothesis could mean a breakthrough 
in the medical field with respect to boosting an early immune 
response.[4] However, there is limited research in this field on 
mammals and there is a need for replication of existing evi-
dence that short-term exposure to ELF-EMF could promote in-
nate immunity and find new evidence to support this theory. 
If there is evidence that short-term exposure to the ELF-EMF 
Immunent BV signal can stimulate the immune system of fish 
and chickens,[21] then it could be possible that the same find-
ings could be reproduced in mammals, specifically mice (Mus. 
musculus), thus endorsing the findings of previous research in 
lower animals. The aim of the current study was to investigate 
whether short-term exposure to ELF-EMF from the specific Im-
munent BV signal could affect the immune system in mice and 
if the duration of exposure to the signal has any significant effect 
on the results. 
METHODOLOGy
The research study was based on a longitudinal study design and 
was conducted at the Central University of Technology (CUT). 
The experimental design involved the following four processes: 
(a) exposure of the mice to the EMF signal; (b) anaesthetisation, 
blood collection and euthanasia of the animals; (c) biological 
analysis; and (d) data capturing and processing for statistical 
analysis. Approval for the study was granted by the animal eth-
ics committee of the UFS (No. 20/08). Rules and regulations of 
the Experimental Animal Act (Review of animal care legislation 
in South Africa, 1962) were strictly adhered to with the help of 
University of the Free State (UFS) Animal Unit where the expo-
sure period was set up and conducted.
The sample comprised one hundred healthy young adult (ap-
proximately six weeks old) male mice of the BALB/c N1H 
strain with a mean weight of 23±1.5 grams. The weight was 
kept within this range to avoid dominant behaviour by larger 
mice. Male mice were chosen in order to exclude hormonal 
influences. Well-ventilated, plastic cylinders were designed and 
built to house the cages containing the mice during the expo-
sure period. Copper coils were spun around each cylinder to 
create the electromagnetic field controlled from the Immunent 
BV exposure control system. The Immunent generator, supplied 
by Immunent BV,[22] was used for the exposure procedure. The 
signal produced by the generator was unique. It consisted of 
multiple waveforms, which created complex, continuously 
changing EMFs with steep rise times and exponential decays. 
The experimental group of mice were uniformly exposed to 
the EMFs (multiple frequencies 20-5000Hz) with an intensity 
of 5µT. Mice were housed in Perspex cages, which were lined 
with sawdust for bedding. The design of the cages allowed free 
access to food and water. The diet consisted of a balanced diet 
of Epol mouse pellets. Cages were visited daily to check on 
food, water, temperature and power supply. Controlled environ-
mental conditions, such as room temperature of 21°C and light 
switches controlling a twelve-hour day and twelve-hour night 
routine were maintained. Human handling of the mice was kept 
to a minimum, to prevent stress in the animals.
The experiment was set up in three experimental groups of 
twenty-five mice each and a control group of twenty-five mice. 
The cages housing the mice were placed inside the cylinders 
where they were exposed to the EMF signal. The duration of dai-
ly exposure for each experimental group (referred to as Groups 
A, B and C) were as follows: (1) twenty-four hours (continu-
ous) for Group A; (2) four hours for Group B; and (3) one hour 
for Group C. The control group (K) was housed in a separate 
room and totally removed from any exposure to EMFs created 
by the Immunent signal. In all other aspects (housing, room 
temperature, lighting, diet and daily visits), the control group 
was treated the same way as the experimental group. The mice 
were subjected to this exposure for 7 days. After completion of 
exposure, the mice were anaesthetised in a chamber containing 
Allantoin gas. This process was performed by qualified person-
nel from the Animal Unit. Approximately 1ml whole blood was 
collected (through orbital bleeding) for the biological analysis. 
The anticoagulant used was ethylenediaminetetraacetic acid 
(EDTA) powder. While anesthetised, mice were euthanized by 
cervical dislocation. 
The white blood cell counts (leukocyte count) were analysed on 
an ABX Pentra 60 blood cell analyser (reagents from Scientific 
Group). The total leukocyte count was determined as well as 
the differential lymphocyte, monocyte, neutrophil, eosinophil 
and basophil values (expressed as percentage of the total leu-
kocytes). High, low and medium controls were included for 
quality control. The immunophenotyping of lymphocyte subsets 
was performed on a Fluorescence-Activated Cell Sorting (FACS) 
Calibur Analyser, using rat anti-mouse markers (from Beckman 
Coulter). Isotype controls were included for all the markers. 
Whole blood was analysed for the total T-lymphocyte (CD3), 
helper T-lymphocyte (CD4), cytotoxic T-lymphocyte (CD8) and 
B-lymphocyte (CD19) values.
Raw data was compiled in Excel and sent for statistical analysis 
by a statistics consultant. Descriptive statistics, namely means 
and standard deviations (or medians and percentiles), were cal-
culated for the different groups. For data producing a Gaussian 
distribution, means and standard deviations were calculated, 
whereas the data producing a non-Gaussian curve, median and 
percentiles were calculated. The mean (or median) values for 
each of the exposure groups were compared individually with 
the mean (or median) value of the control group using the t-test 
(or Kruskal-Wallis test) for independent samples. The ANOVA 
test (or Kruskal-Wallis test) was used for comparison between 
the exposure groups (intergroup comparison). A significance 
level of 0.05 was used.
REsULTs
The leukocyte values and immunophenotyping from 100 mice 
were analysed. Results from clotted samples were disregarded 
for analysis. A summary of the results from the leukocyte values 
and immunophenotyping is captured in Tables 1-4. It should be 
noted that the differential leukocyte values and immunophe-
notyping values were expressed as percentage values. The 
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histograms in Figures 1-3 illustrate only the results showing sig-
nificant differences. The mean (median) for the exposure groups 
versus the control group are presented (Table 1 and 3), in an 
attempt to determine whether the exposure had an effect on 
the cell values. This is followed by the intergroup comparison 
(Table 2 and 4) to determine whether the duration of exposure 
had an effect on cell values.
Leukocyte values
The descriptive statistics and statistical significance for mean or 
median differences between the various experimental groups 
and the control group for the leukocyte parameters are depicted 
in the Table 1 and figures 1a-1c.
The data revealed a significant mean or median difference in 
total leukocyte (p=0.0391), lymphocyte (p=0.0149) and neu-
trophil (p=0.0014) values between group A (twenty four hour) 
and the control group. For the monocytes, eosinophils and ba-
sophils, there were no significant median differences between 
the experimental groups and the control group (p>0.05). In fig-
ures 1a-1c the total leukocyte and lymphocyte values for group 
A was significantly higher than that of the control group, where-
as the neutrophil values of group A was significantly lower.
From these histograms it is also evident that the difference be-
tween the exposure groups and the control group seemed to 
increase as the duration of exposure time increased. In spite 
of the differences not all being statistically significant, many 
parameters were found to be significant in group A, which re-
ceived the maximum exposure duration. A similar observation 
was made for the decreased neutrophil values.
Table 2 and Figures 2a-2c depict the differences for leukocyte 
parameters between all of the groups (ANOVA test) and be-
tween the individual groups (intergroup comparison).
The results in Table 2 indicate no significant intergroup varia-
Table 1: Descriptive statistics and p-values for mean and median leukocyte parameters of the experimental and control groups.
Parameter A (24hr) B (4hr) C (1hr) K (Control)
Total leukocytes
Mean (109 /L) 7.26 7.06 6.66 6.33
SD 1.66 1.44 1.42 1.39
p-value t-test 0.0391* 0.0773 0.4032
Lymphocytes
Median (%) 89.25 87.30 87.10 87.10
Inter-quartile range 87.3-92.55 85.60-90.90 85.50-89.20 84.25-89.05
p-value Kruskal-Wallis test 0.0149* 0.4715 0.5555
Monocytes
Median (%) 2.60 3.00 3.10 3.25
Inter-quartile range 1.70-3.60 2.30-3.80 2.20-4.10 2.50-4.90
p-value Kruskal-Wallis test 0.0833 0.5549 0.6309
Neutrophils
Median (%) 6.50 8.60 8.70 9.00
Inter-quartile range 5.60-8.70 6.90-10.10 7.20-10.20 7.80-9.85
p-value Kruskal-Wallis test 0.0014* 0.2712 0.6169
Eosinophils
Median (%) 0.10 0.20 0.20 0.20
Inter-quartile range 0.10-0.20 0.10-0.30 0.10-0.40 0.10-0.40
p-value Kruskal-Wallis test 0.1360 0.9030 0.8469
Basophils
Median (%) 0.40 0.40 0.40 0.40
Inter-quartile range 0.30-0.50 0.30-0.50 0.30-0.40 0.30-0.50
p-value Kruskal-Wallis test 0.6656 0.8356 0.2562
*(p<0.05 indicates significant difference)
Figures 1a-c: Mean or median values for the total leukocytes (a), lymphocytes (b), and neutrophils (c) of all the groups (*significant difference p<0.05)
(1a) (1b) (1c)
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tion for the total leukocyte, monocyte, eosinophil and basophil 
results (p>0.05). There was, however, a significant variation 
shown by the ANOVA test between the three groups for the 
lymphocyte (p=0.0338) and neutrophil (p=0.0190) paramaters 
(Figures 2a and 2b).
The results for the lymphocyte percentage indicated a signifi-
cant median difference between groups A and B (p=0.0423) 
as well as between groups A and C (p=0.0151), but none was 
found between groups B and C (p>0.05). For the neutrophils, 
there was a significant median difference between groups A and 
B (p=0.0435) as well as between groups A and C (p=0.0072), 
and, as with the lymphocytes, none was found between groups 
B and C (p>0.05). For both the parameters, the most significant 
median differences were found between groups A and C. Once 
again, it is evident that the longer the exposure duration, the 
more significant the difference became.
Immunophenotyping
The descriptive statistics and statistical significance for mean 
differences between the experimental groups and the control 
group for the immunophenotyping results are summarised in 
Table 2: Intergroup comparison for leukocyte parameters of the experimental and control groups.
Parameter
A vs. B vs. C 
(ANOVA/ Kruskal-
Wallis test) p-value
A vs. B (t-test/ 
Kruskal-Wallis test) 
p-value
A vs. C (t-test/ 
Kruskal-Wallis test) 
p-value
B vs. C (t-test/ 
Kruskal-Wallis test) 
p-value
Total leukocytes 0.3772 0.6520 0.1830 0.3385
Lymphocytes 0.0338* 0.0423* 0.0151* 0.7195
Monocytes 0.1563 0.1272 0.0771 0.7709
Neutrophils 0.0190* 0.0435* 0.0072* 0.4786
Eosinophils 0.2636 0.2379 0.1219 0.6228
Basophils 0.1475 0.7251 0.0945 0.0879
*(p<0.05 indicates significant difference)
Figures 2a & b: Intergroup comparison of median, lymphocyte and neutrophils values (*significant difference p<0.05)
(2a) (2b)
Table 3: Descriptive statistics and p-values for mean immunophenotyping parameters of the experimental and control groups.
Parameter A (24hr) B (4hr) C (1hr) K (Control)
CD3
Median (%) 34.13 34.17 35.77 25.70
SD 8.86 11.64 11.01 13.73
p-value t-test 0.0218* 0.0372* 0.0137*
CD4
Median (%) 26.52 25.72 26.87 19.20
SD 7.01 8.65 8.81 11.11
p-value t-test 0.0138* 0.0400* 0.0193*
CD8
Median (%) 8.37 8.43 9.94 6.7
SD 2.96 3.35 2.85 3.19
p-value t-test 0.0762 0.0934 0.0015*
CD19
Median (%) 23.08 23.22 17.32 17.88
SD 12.10 12.03 12.78 13.77
p-value t-test 0.1849 0.1885 0.8933
*(p<0.05 indicates significant difference)
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Table 3. The immunophenotyping parameters are expressed as 
percentage values.
There was a significant increase in the CD3 percentage of groups 
A (p=0.0218), B (p=0.0372) and C (p=0.0137) compared to the 
control group. In addition, a significant mean difference in CD4 
between groups A (p=0.0138), B (p=0.0400), C (p=0.0193) and 
the control group was found. For CD8, only group C showed a 
significant mean difference (p=0.0015) from that of the control 
group. No significant mean differences were found between 
any of the exposure groups and the control group for CD19 
percentages. A remarkable finding in this part of the study was 
that in spite of the fact that the total lymphocyte values were 
higher than the control group in only the continuously exposed 
group (Group A), the CD3 and CD4 (T lymphocyte) values were 
found to be higher in all of the exposure groups.
Table 4 indicates the differences between all of the groups 
(ANOVA test) and between the individual groups (intergroup 
comparison). In this case no significant differences (p>0.05) 
were found between any of the exposure groups for the immu-
nophenotyping parameters. The ANOVA test (A vs. B vs. C) in-
dicated no significant differences (p>0.05) between the groups 
for the immunophenotyping parameters.
DIsCUssION
The comparative data between the various exposure groups 
and the control group revealed that there was a significant 
difference in lymphocyte and neutrophil results between the 
exposure groups and the control groups; indicating a strong 
possibility that short-term exposure to ELF-EMF could stimulate 
the immune response. The intergroup comparison revealed that 
there was a significant variation between the different groups 
for the lymphocyte and neutrophil results; suggesting that the 
duration of exposure had an effect on the cell values.
Most of the statistically significant differences were evident in 
the lymphocyte parameters. The immunophenotyping analysis 
for specific lymphocyte sub-populations revealed that these 
significant differences were limited to T-lymphocytes. The 
increased lymphocyte value most likely accounted for the 
increased total leukocyte count, which was confirmed by the 
immunophenotyping results in Table 3. It can also be deduced 
Table 4: Intergroup comparison for immunophenotyping parameters of the experimental and control groups.
Parameter
A vs. B vs. C 
(ANOVA) p-value
A vs. B (t-test) 
p-value
A vs. C (t-test) 
p-value
B vs. C (t-test) 
p-value
CD3 0.3772 0.6520 0.1830 0.3385
CD4 0.0338 0.0423 0.0151 0.7195
CD8 0.1563 0.1272 0.0771 0.7709
CD19 0.0190 0.0435 0.0072 0.4786
*(p<0.05 indicates significant difference)
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from the immunophenotyping that T-lymphocytes represented 
the specific group of lymphocytes that was increased. The 
significant differences for the leukocyte parameters in Table 1 
suggest that exposure to the ELF-EMF signal did have an effect 
on the leukocyte values. There was also an apparent variation 
between the groups for the leukocyte values, where the ten-
dency increased with an increase in the duration of exposure. 
The most significant difference was found in group A (twenty 
four hour exposure), the experimental group which received the 
maximum daily exposure. Hence, the deduction that the longer 
the exposure, the more significant the difference became. This 
provides evidence that the duration of exposure plays an im-
portant role or has an effect on the immune cell values. This 
effect, as a result of duration of exposure, was also reported by 
Goraca et al.[15] when they suggested that the oxidative stress 
parameters depended on “working time” (duration of exposure) 
of the ELF-EMF field.
In the human body, immune stimulation is characterised by an 
increased lymphocyte count, due to activation of lymphocytes 
when stimulated by a “foreign agent or stimulus”.[23] Hence, the 
increased leukocyte count in this study could possibly indicate 
an immune stimulation. Markov et al.[14] indicated that ELF-
EMFs interact with lymphocytes and Selmaoui et al.[24] found 
an increased IL-6 in healthy young men exposed to a 9-hour 
intermittent field (10µT). An increased leukocyte count could, 
therefore, be due to increased cytokine production.[17,21,22] This 
could explain the association of the increased lymphocyte 
concentration in this study. The reason for this is that activa-
tion of the innate immune system is accompanied by cytokine 
production.[4] Cytokines play an important role in T-lymphocyte 
differentiation in the immune response.[23] Once stimulated, 
the immune system is no longer in a state of homeostasis. In 
a study by Markov et al.[14] they found that ELF-EMF affected 
homeostatically unstable cells. This concurs with the hypothesis 
of Cuppen et al.[17] that ELF-EMF exposure can “put the immune 
system into a state of alert”.
The reason for the decreased neutrophil values in this current 
study is unclear. In the study by Elmusharaf et al.[19] the authors 
suggested that EMF treatment could possibly result in increased 
blood flow, just like it would in an inflammatory reaction, hence 
leading to relocalization or colonization of phagocytic cells to 
potentially damaged tissues.[20] The author is of opinion that this 
suggestion could possibly explain the reduced neutrophil count 
in our study. In other words, the neutrophil value was decreased 
in the peripheral blood due to relocation of these cells to the 
tissues when being stimulated by ELF-EMF. De Kleijn et al.[4] 
mention that inflammatory cytokines play a role in regulation 
of other immune cells such as neutrophils. Coico, Sunshine 
and Benjamini[22,23] explain neutrophil migration (also known 
as transendothelial migration) under the influence of cytokines. 
One of the cytokines involved in this process is IL-8. A possible 
explanation for the decreased neutrophil count could then be 
due to IL-8 release following activation of lymphocytes with 
consequent relocation of neutrophils to the tissues. The finding 
of increased phagocytic activity following short-term exposure 
to ELF-EMF has been described by several authors.[4,13,15,26,27] In 
yet another study, increased macrophage activity was found to 
be associated with increased superoxide anion (O2/free radical) 
production.[25] However, these analyses were not performed in 
this study, but could direct toward consideration for future re-
search. Varani et al.[28] found that ELF-EMF exposure resulted in 
an increase of A2A adenosine receptor density in neutrophils. 
Adenosine receptors interact on the neutrophil surface as an 
anti-inflammatory agent.[29] This A2A adenosine receptor could 
be considered as yet another possibility of a biological mecha-
nism explaining the involvement of neutrophils in the immune 
response following exposure to ELF-EMF.
Taking a critical look at the results obtained for the immunophe-
notyping, it was found that short-term exposure to ELF-EMF 
resulted in increased CD3 and CD4 lymphocyte values for all 
the exposure groups (twenty-four, four and one hour exposure). 
The most significant increase in values was seen in group C (one 
hour exposure). There was also a significant increase in CD8 
counts for group C. No significant differences were found for 
the CD19 values. Therefore, short-term exposure to the specific 
Immunent signal resulted in increased T-lymphocyte values, but 
had no effect on B-cell values. Since no significant differences 
were found in the intergroup comparison, it can be deduced 
that the duration of exposure did not affect the results of the 
immunophenotyping. A possible explanation for the increased 
CD3 and CD4 lymphocyte percentages for all the exposure 
groups could be that the T-lymphocytes were signalled by 
the increased IL-6 levels. This fits in well with the findings by 
Selmaoui et al.[24] who reported raised IL-6 levels in young men 
when exposed to 50Hz EMFs. The increase, and possible activa-
tion, of CD4 cells can then result in activation and increased 
number of CD8 cells.[25] Aldinucci & Pessina[18] demonstrated 
increased proliferative response and cytokine (INFγ and IL-6) 
release when cells were expose to ELF-EMF. IL-6 activates T-
cells and IL-2 production CD4 cells also produce IL-2 which, 
in turn, induces proliferation and differentiation of CD8 cells.[25] 
This could possibly be the outcome of the underlying biologi-
cal process resulting in the increased CD4 values and also the 
increased CD8 values in group C. These results agree well with 
the results for the leukocyte parameters of the current study, 
confirming that the increased lymphocyte values were limited 
to the T-lymphocytes and that cytokine involvement in this proc-
ess cannot be excluded.
The results from the current study revealed evidence of immune 
stimulation in mice after short-term exposure to the Immunent 
signal. Since the biological analysis involved cell counts, it is 
evident that the effect on the immune system is at cellular level. 
Specific cells that indicated this effect were the T-lymphocyte 
population. This was confirmed in both the full blood count and 
the immunophenotyping. The findings of the current study also 
suggest that the longer the duration of exposure, the greater the 
effect on the cell values. It should be kept in mind, however, 
that the exposure duration for the current study was limited to 
seven days. The researcher is of the opinion that the critical is-
sue in this study was the dosimetry and the physical characteris-
tics of the signal. Future investigations are advised which target 
the understanding of the biological mechanisms, using the Im-
munent exposure system and repeating all the experiments from 
the current study on higher animals, such as swine or primates. 
Further research on the mechanism of neutrophil involvement, 
specifically on cytokine level, is advised. Specific recommenda-
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tions include a repeat of the current experiment and determin-
ing interleukin-2, interleukin-6 and interleukin-8 levels.
CONCLUsION
From this study, it can be concluded that short-term (seven days) 
exposure to the Immunent signal can stimulate the immune re-
sponse on a cellular level and that the duration of exposure 
plays a role on this effect. The subsequent health effects and 
potential therapeutic application could be beneficial, not only 
in health departments, but also in the farming industry where a 
significant amount of research has already produced evidence 
proving the benefits of the Immunent signal.
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